Financhill
Sell
47

SLNCF Quote, Financials, Valuation and Earnings

Last price:
$1.75
Seasonality move :
-3.27%
Day range:
$1.75 - $1.75
52-week range:
$0.50 - $2.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
123.28x
P/B ratio:
3.35x
Volume:
--
Avg. volume:
148
1-year change:
19.05%
Market cap:
$248M
Revenue:
$43.3M
EPS (TTM):
-$0.79

Earnings Data

Next earnings date for SLNCF
Mar 05
2026
Most recent earnings per share
-$0.15
Missed by $0.15
(Nov 6/2025)
Consensus Estimate
--
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SLNCF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $1.1M -- -- -- --
03/05/2026 Q4 $1.6M -- -- -- --
11/06/2025 Q3 $4.4M $159K -$0.15 -- --
08/15/2025 Q2 $4.6M $224K -$0.19 -- --
05/08/2025 Q1 $4.2M $142K -$0.20 -$0.15 -$0.05
02/27/2025 Q4 $4.8M -- -- -- --
11/14/2024 Q3 $3.9M $1.5M -$0.25 -$0.14 -$0.11
08/15/2024 Q2 $12.4M $754.5K -$0.14 -$0.08 -$0.06
05/16/2024 Q1 $4.5M $15.7M -$0.02 -$0.13 $0.11
03/13/2024 Q4 $11.6M $2.6M -$0.15 -$0.14 -$0.01
11/14/2023 Q3 $3.1M $3.5M -$0.09 -$0.18 $0.09
08/16/2023 Q2 -- $11.4M -$0.12 -- --
05/16/2023 Q1 -- $13.8M -$0.11 -- --
03/15/2023 Q4 -- $5.6M -$0.15 -- --
11/10/2022 Q3 -- $4M -$0.08 -- --
09/27/2022 Q2 -- $4.6M -$0.17 -- --
05/16/2022 Q1 -- $7.7M -$0.11 -- --
03/17/2022 Q4 -- $4.7M -$0.14 -- --
11/16/2021 Q3 -- $4.2M -$0.15 -- --
06/30/2021 Q2 -- $3.7M -$0.18 -- --
03/31/2021 Q1 -- $4.3M -$0.13 -- --
12/31/2020 Q4 -- $3.4M -$0.22 -- --
09/30/2020 Q3 -- $2.6M -$0.14 -- --

Silence Therapeutics Plc Earnings Questions

  • How Much did Silence Therapeutics Plc Generate in Revenue Last Quarter?

    Silence Therapeutics Plc reported $159K worth of top line sales in its most recent quarter.

  • Did Silence Therapeutics Plc Beat Earnings Last Quarter?

    Silence Therapeutics Plc announced earnings per share of -$0.15 which represents a miss of analyst forecast a -- per share.

  • Is Silence Therapeutics Plc Profitable?

    Silence Therapeutics Plc reported -$20.5K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Silence Therapeutics Plc EPS Next Year?

    Silence Therapeutics Plc's earnings are forecast to decrease from -$0.33 per share to -$0.57 per share next year representing a decrease of -74.8%.

  • When is Silence Therapeutics Plc's Earnings Date?

    Currently, Silence Therapeutics Plc has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on June 4, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 37x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
42
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
93
NBTX alert for Mar 5

Nanobiotix SA [NBTX] is down 7.15% over the past day.

Sell
45
MRNA alert for Mar 5

Moderna, Inc. [MRNA] is down 6.83% over the past day.

Buy
77
SSRM alert for Mar 5

SSR Mining, Inc. [SSRM] is down 6.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock